David A. Spellman - May 16, 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, CFO and Treasurer
Signature
/s/ Carolyn Rucci, attorney-in-fact for David A. Spellman
Stock symbol
AKBA
Transactions as of
May 16, 2023
Transactions value $
-$67,890
Form type
4
Date filed
5/18/2023, 06:19 PM
Previous filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$67.9K -63.6K -12.46% $1.07 446K May 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on June 8, 2022.